论文部分内容阅读
与数年至数十年前人们主要关注革兰氏阴性杆菌感染症相反,近年来由于感染症病原菌发生变化,革兰氏阳性球菌、尤是耐甲氧西林金黄色葡萄球菌(MRSA)、耐青霉素肺炎球菌(PRSP)和A群溶血性链球菌等好氧性革兰氏阳性球菌所致的感染症已开始成为各种有关感染症及其化学疗法的学术会议与杂志讨论的热点和焦点,并正因其难治性甚或缺乏有效的控制手段而引起了全球社会的广泛注意。鉴于临床需求即是市场,故现在国外
In contrast to the predominant concern of Gram-negative bacilli in decades and decades ago, Gram-positive cocci, especially methicillin-resistant Staphylococcus aureus (MRSA) Infectious diseases caused by aerobic gram-positive cocci, such as penicillin-resistant pneumococci (PRSP) and streptococci group A have become the hot topics and focus of academic conferences and magazines on various infectious diseases and chemotherapies. And it is precisely because of its refractory or even lack of effective control measures caused widespread attention of the global community. In view of the clinical needs that the market, it is now abroad